| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | INTERCEPT PHARMACEUTICALS INCORPORATED | 13,500 | 2,222,000 | 0.40% | ||
| 52 | IMPAX LABORATORIES INC | 95,000 | 2,252,000 | 0.41% | ||
| 53 | ANGIODYNAMICS INC | 130,000 | 2,280,000 | 0.41% | ||
| 54 | SEATTLE GENETICS INC | 43,000 | 2,322,000 | 0.42% | ||
| 55 | ZELTIQ AESTHETICS INC | 60,000 | 2,353,000 | 0.43% | ||
| 56 | HCA HOLDINGS INC | 31,200 | 2,360,000 | 0.43% | ||
| 57 | AGIOS PHARMACEUTICALS INC | 45,000 | 2,377,000 | 0.43% | ||
| 58 | ALKERMES PLC | 51,500 | 2,422,000 | 0.44% | ||
| 59 | PROTHENA CORP PLC | 41,000 | 2,459,000 | 0.44% | ||
| 60 | MACROGENICS INC | 83,000 | 2,483,000 | 0.45% | ||
| 61 | QIAGEN NV | 91,500 | 2,511,000 | 0.45% | ||
| 62 | THERMO FISHER SCIENTIFIC INC | 16,000 | 2,545,000 | 0.46% | ||
| 63 | ANTHEM INC | 20,600 | 2,581,000 | 0.47% | ||
| 64 | NOVADAQ TECHNOLOGIES INC | 230,000 | 2,661,000 | 0.48% | ||
| 65 | LILLY ELI & CO | 35,000 | 2,809,000 | 0.51% | ||
| 66 | MERCK & CO INC | 47,000 | 2,933,000 | 0.53% | ||
| 67 | NEUROCRINE BIOSCIE COM USD0.001 | 58,000 | 2,937,000 | 0.53% | ||
| 68 | ULTRAGENYX PHARMACEUTICAL INC COM | 43,000 | 3,050,000 | 0.55% | ||
| 69 | NEKTAR THERAPEUTICS COM | 186,000 | 3,195,000 | 0.58% | ||
| 70 | Intersect ENT Inc | 205,325 | 3,252,000 | 0.59% | ||
| 71 | RADIUS HEALTH INCORPORATED COM NEW | 61,000 | 3,299,000 | 0.60% | ||
| 72 | EXPRESS SCRIPTS HLDG CO | 49,500 | 3,491,000 | 0.63% | ||
| 73 | AURIS MED HLDG AG | 2,169,625 | 3,753,000 | 0.68% | ||
| 74 | ENDO INTL PLC | 190,000 | 3,829,000 | 0.69% | ||
| 75 | HALOZYME THERAPEUTICS INC | 318,000 | 3,841,000 | 0.69% | ||
| 76 | ISHARES TR | 13,500 | 3,908,000 | 0.71% | ||
| 77 | PERRIGO CO PLC | 42,700 | 3,942,000 | 0.71% | ||
| 78 | IONIS PHARMACEUTICALS INC COM | 108,000 | 3,957,000 | 0.71% | ||
| 79 | NUVASIVE INC | 60,000 | 4,000,000 | 0.72% | ||
| 80 | MCKESSON CORP | 24,000 | 4,002,000 | 0.72% | ||
| 81 | MASIMO CORP | 70,000 | 4,164,000 | 0.75% | ||
| 82 | COOPER COS INC | 23,500 | 4,213,000 | 0.76% | ||
| 83 | AMSURG CORP | 71,400 | 4,787,000 | 0.86% | ||
| 84 | COHERUS BIOSCIENCES INC COM | 202,000 | 5,410,000 | 0.98% | ||
| 85 | BARD C R INC | 25,000 | 5,607,000 | 1.01% | ||
| 86 | MALLINCKRODT PUB LTD CO | 80,800 | 5,638,000 | 1.02% | ||
| 87 | JOHNSON & JOHNSON | 50,000 | 5,907,000 | 1.07% | ||
| 88 | BIOMARIN PHARMACEUTICAL INC | 65,000 | 6,014,000 | 1.09% | ||
| 89 | ALEXION PHARMACEUTIC | 49,400 | 6,053,000 | 1.09% | ||
| 90 | CERNER CORP | 98,500 | 6,082,000 | 1.10% | ||
| 91 | ALLERGAN PLC | 29,400 | 6,771,000 | 1.22% | ||
| 92 | ARIAD PHARMACEUTICALS ORD (NMS) | 495,000 | 6,777,000 | 1.22% | ||
| 93 | AKORN INCORPORATED | 252,000 | 6,870,000 | 1.24% | ||
| 94 | ABIOMED INC | 55,450 | 7,130,000 | 1.29% | ||
| 95 | SHIRE PLC | 38,090 | 7,384,000 | 1.33% | ||
| 96 | VERTEX PHARMACEUTICALS INC | 85,000 | 7,413,000 | 1.34% | ||
| 97 | CIGNA CORPORATION | 59,722 | 7,783,000 | 1.41% | ||
| 98 | INCYTE CORP | 91,000 | 8,580,000 | 1.55% | ||
| 99 | TEVA PHARMACEUTICAL INDS LTD | 187,190 | 8,613,000 | 1.56% | ||
| 100 | INTUITIVE SURGICAL INC | 12,000 | 8,698,000 | 1.57% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-021740, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
